Financial Snapshot

Revenue
$32.87M
TTM
Gross Margin
89.5%
TTM
Net Earnings
$674.3M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
899.27%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$1.627B
Q3 2024
Cash
Q3 2024
P/E
5.028
Nov 29, 2024 EST
Free Cash Flow
-$330.1M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue $26.82M $14.24M $0.00 $203.2M $117.9M $94.39M $43.01M $69.89M $59.12M $65.36M $25.55M $25.11M $21.84M
YoY Change 88.36% -100.0% 72.33% 24.92% 119.45% -38.46% 18.22% -9.55% 155.82% 1.76% 14.97%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue $26.82M $14.24M $0.00 $203.2M $117.9M $94.39M $43.01M $69.89M $59.12M $65.36M $25.55M $25.11M $21.84M
Cost Of Revenue $2.881M $1.704M $0.00 $2.805M $1.317M $1.397M $0.00 $0.00
Gross Profit $23.94M $12.54M $0.00 $200.4M $116.6M $92.99M $43.01M $69.89M
Gross Profit Margin 89.26% 88.03% 98.62% 98.88% 98.52% 100.0% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Selling, General & Admin $119.9M $121.7M $121.4M $115.1M $102.0M $114.1M $71.12M $50.71M $36.00M $19.10M $9.900M $7.100M $7.200M
YoY Change -1.45% 0.19% 5.51% 12.84% -10.63% 60.49% 40.25% 40.87% 88.48% 92.93% 39.44% -1.39%
% of Gross Profit 500.81% 970.59% 57.44% 87.49% 122.75% 165.36% 72.56%
Research & Development $295.5M $279.9M $257.0M $220.8M $214.3M $341.3M $292.7M $220.2M $141.8M $100.4M $54.50M $41.04M $31.25M
YoY Change 5.58% 8.93% 16.38% 3.06% -37.23% 16.62% 32.94% 55.23% 41.3% 84.16% 32.81% 31.31%
% of Gross Profit 1234.34% 2232.85% 110.19% 183.77% 367.05% 680.48% 315.0%
Depreciation & Amortization $6.600M $8.400M $8.800M $9.400M $8.087M $7.172M $6.432M $5.700M $3.342M $1.367M $1.440M $1.179M $801.0K
YoY Change -21.43% -4.55% -6.38% 16.24% 12.76% 11.5% 12.84% 70.56% 144.48% -5.07% 22.14% 47.19%
% of Gross Profit 27.57% 67.01% 4.69% 6.94% 7.71% 14.95% 8.16%
Operating Expenses $415.4M $401.6M $378.4M $335.9M $316.3M $456.9M $363.8M $270.9M $177.8M $119.5M $64.43M $48.10M $38.47M
YoY Change 3.45% 6.12% 12.65% 6.21% -30.77% 25.58% 34.31% 52.33% 48.81% 85.46% 33.95% 25.04%
Operating Profit -$391.5M -$389.0M -$378.4M -$335.9M -$316.3M -$362.5M -$320.8M -$201.0M -$118.7M -$54.13M -$38.88M -$23.00M -$16.63M
YoY Change 0.63% 2.81% 12.65% 6.21% -12.75% 12.99% 59.61% 69.32% 119.27% 39.22% 69.09% 38.27%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Interest Expense $33.34M $12.79M $836.0K $6.600M $14.90M $16.50M $6.100M $2.500M $1.000M $200.0K $100.0K $100.0K $100.0K
YoY Change 160.64% 1430.26% -87.33% -55.7% -9.7% 170.49% 144.0% 150.0% 400.0% 100.0% 0.0% 0.0%
% of Operating Profit
Other Income/Expense, Net $6.055M $6.749M $14.43M $0.00 $0.00
YoY Change -10.28% -53.24%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Pretax Income -$352.1M -$231.8M -$356.5M -$329.3M -$301.4M -$311.2M -$290.4M -$198.5M -$117.7M -$53.93M -$38.83M -$22.93M -$16.50M
YoY Change 51.89% -34.98% 8.26% 9.26% -3.13% 7.14% 46.33% 68.58% 118.31% 38.89% 69.36% 38.95%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 -$426.0K $579.0K -$2.824M $7.207M
% Of Pretax Income
Net Earnings -$352.1M -$231.8M $1.605B -$327.4M -$411.5M -$346.0M -$314.7M -$198.5M -$117.7M -$53.50M -$39.41M -$20.10M -$23.71M
YoY Change 51.89% -114.44% -590.18% -20.44% 18.91% 9.97% 58.55% 68.58% 120.04% 35.77% 96.04% -15.2%
Net Earnings / Revenue -1312.63% -1627.82% -161.11% -348.97% -366.61% -731.6% -283.97% -199.14% -81.86% -154.25% -80.07% -108.56%
Basic Earnings Per Share -$6.33 -$4.23 $26.55 -$4.74 -$6.86
Diluted Earnings Per Share -$6.33 -$4.23 $26.55 -$4.74 -$6.86 -$6.028M -$6.753M -$5.077M -$3.147M -$1.588M -$2.558M -$5.912M -$7.900M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Cash & Short-Term Investments $776.9M $783.1M $1.020B $572.9M $564.9M $585.3M $423.9M $541.3M $317.0M $342.1M $166.8M $128.0M $179.2M
YoY Change -0.79% -23.22% 78.04% 1.42% -3.49% 38.08% -21.69% 70.76% -7.34% 105.1% 30.31% -28.57%
Cash & Equivalents $88.21M $139.3M $203.1M $127.4M $80.90M $70.50M $102.7M $160.8M $71.80M $14.00M $71.60M $91.30M $117.7M
Short-Term Investments $688.7M $643.9M $816.9M $445.5M $483.9M $514.8M $321.2M $380.6M $245.2M $328.0M $95.20M $36.70M $61.50M
Other Short-Term Assets $35.02M $38.96M $39.84M $23.70M $24.20M $17.20M $17.50M $10.30M $8.700M $8.600M $2.500M $2.100M $11.40M
YoY Change -10.1% -2.21% 68.08% -2.07% 40.7% -1.71% 69.9% 18.39% 1.16% 244.0% 19.05% -81.58%
Inventory $19.08M $8.492M $14.70M $7.300M $900.0K
Prepaid Expenses
Receivables $2.810M $2.206M $21.30M $11.90M $7.300M $1.200M
Other Receivables $0.00 $0.00 $4.100M $3.400M $3.100M $2.600M
Total Short-Term Assets $833.8M $832.8M $1.064B $636.7M $611.7M $613.8M $445.3M $559.9M $337.3M $359.5M $169.7M $130.1M $190.6M
YoY Change 0.13% -21.75% 67.15% 4.09% -0.34% 37.84% -20.47% 65.99% -6.18% 111.84% 30.44% -31.74%
Property, Plant & Equipment $69.79M $88.12M $104.2M $117.5M $126.1M $24.30M $24.40M $25.30M $23.20M $6.400M $3.800M $3.600M $3.200M
YoY Change -20.8% -15.46% -11.29% -6.82% 418.93% -0.41% -3.56% 9.05% 262.5% 68.42% 5.56% 12.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $29.44M $313.9M $266.4M $97.60M $152.9M $220.1M $143.8M $32.30M $58.90M $125.4M $27.10M
YoY Change -90.62% 17.83% 172.93% -36.17% -30.53% 53.06% 345.2% -45.16% -53.03% 362.73%
Other Assets $4.057M $3.956M $2.900M $1.100M $0.00 $200.0K $900.0K $1.600M $600.0K $600.0K $600.0K $3.300M $700.0K
YoY Change 2.55% 36.41% 163.64% -100.0% -77.78% -43.75% 166.67% 0.0% 0.0% -81.82% 371.43%
Total Long-Term Assets $103.3M $405.9M $373.5M $216.3M $279.0M $244.7M $169.1M $59.20M $82.80M $132.4M $31.50M $6.900M $3.900M
YoY Change -74.56% 8.69% 72.68% -22.47% 14.02% 44.71% 185.64% -28.5% -37.46% 320.32% 356.52% 76.92%
Total Assets $937.1M $1.239B $1.438B $853.0M $890.7M $858.5M $614.4M $619.1M $420.1M $491.9M $201.2M $137.0M $194.5M
YoY Change
Accounts Payable $9.780M $18.62M $16.70M $26.80M $21.90M $17.90M $22.80M $17.10M $14.70M $11.10M $3.700M $3.300M $3.600M
YoY Change -47.46% 11.47% -37.69% 22.37% 22.35% -21.49% 33.33% 16.33% 32.43% 200.0% 12.12% -8.33%
Accrued Expenses $58.18M $44.01M $42.80M $67.20M $59.80M $42.10M $34.00M $32.00M $16.00M $14.00M $6.600M $1.700M $1.500M
YoY Change 32.18% 2.85% -36.32% 12.37% 42.04% 23.82% 6.25% 100.0% 14.29% 112.12% 288.24% 13.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $331.0K $300.0K $300.0K
YoY Change -100.0% 10.33% 0.0%
Total Short-Term Liabilities $67.96M $62.63M $59.83M $94.40M $92.90M $93.50M $94.90M $88.40M $52.90M $61.10M $36.90M $35.10M $48.20M
YoY Change 8.5% 4.69% -36.63% 1.61% -0.64% -1.48% 7.35% 67.11% -13.42% 65.58% 5.13% -27.18%
Long-Term Debt $0.00 $0.00 $276.0K $300.0K $700.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -8.0% -57.14%
Other Long-Term Liabilities $58.14M $75.28M $85.66M $358.7M $156.7M $77.40M $144.0M $172.1M $22.10M $6.400M $32.80M $58.00M $83.20M
YoY Change -22.76% -12.12% -76.12% 128.91% 102.45% -46.25% -16.33% 678.73% 245.31% -80.49% -43.45% -30.29%
Total Long-Term Liabilities $58.14M $75.28M $85.94M $359.0M $157.4M $77.40M $144.0M $172.1M $22.10M $6.400M $32.80M $58.00M $83.20M
YoY Change -22.76% -12.4% -76.06% 128.08% 103.36% -46.25% -16.33% 678.73% 245.31% -80.49% -43.45% -30.29%
Total Liabilities $126.1M $137.9M $145.8M $453.5M $250.2M $170.9M $238.9M $260.5M $74.90M $67.50M $69.70M $93.10M $131.3M
YoY Change -8.56% -5.39% -67.86% 81.25% 46.4% -28.46% -8.29% 247.8% 10.96% -3.16% -25.13% -29.09%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Basic Shares Outstanding 55.65M shares 54.79M shares 60.45M shares 69.00M shares 59.99M shares
Diluted Shares Outstanding 55.65M shares 54.79M shares 60.45M shares 69.00M shares 59.99M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $3.3904 Billion

About AGIOS PHARMACEUTICALS, INC.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. The company is headquartered in Cambridge, Massachusetts and currently employs 383 full-time employees. The company went IPO on 2013-07-24. The firm is focused on developing and delivering transformative therapies for patients living with rare diseases. The company markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The firm is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.

Industry: Pharmaceutical Preparations Peers: Allogene Therapeutics, Inc. Travere Therapeutics, Inc. IOVANCE BIOTHERAPEUTICS, INC. IRONWOOD PHARMACEUTICALS INC Lyell Immunopharma, Inc. MYRIAD GENETICS INC NOVAVAX INC Revolution Medicines, Inc. Xencor Inc